期刊文献+

地佐辛注射液对腹腔镜胆囊切除术全麻苏醒期不良反应的影响 被引量:19

Influence of dezocine injection to the side effects during tracheal extubation period in laparoscopic cholecystectomy
下载PDF
导出
摘要 目的:探讨地佐辛注射液对腹腔镜胆囊切除术(laparoscopic cholecystectomy,LC)病人全麻苏醒期不良反应的影响。方法:选择90例择期行腹腔镜胆囊切除术患者,随机均分为3组:地佐辛组(男16例,女14例)、芬太尼组(男15例,女15例)、曲马多组(男17例,女13例)。术毕关气腹前各组分别以地佐辛0.1mg/kg,芬太尼0.002mg/kg,曲马多2mg/kg静脉注射镇痛。3组病人均用咪达唑仑+异丙酚+舒芬太尼+顺式阿曲库铵静脉诱导后行气管插管,术中以吸入七氟醚和持续静注异丙酚麻醉。观察并记录各组24h内视觉模拟疼痛(VAS)评分、Ramsay镇静评分及不良反应发生例数。结果:地佐辛组和芬太尼组在0.5、1、4h观察时段VAS评分明显低于曲马多组,差异均有统计学意义(P<0.05),12、24h各观察时段3组VAS评分差异无统计学意义;地佐辛组在0.5、1h观察时段Ramsay镇静评分显著高于芬太尼组和曲马多组(P<0.05),3组病例4、12和24h各观察时段Ram-say镇静评分差异无统计学意义(P<0.05);地佐辛组无恶心、呕吐,芬太尼组恶心4例、呕吐0例,曲马多组恶心14例、呕吐7例。结论:地佐辛静脉注射对全麻苏醒期不良反应有良好的治疗效果,用于腹腔镜胆囊切除术病人安全有效。 lower than those of the tramadol group at 0.5, 1,4 h after operation, there was statistical signif- icance(P〈0.05). The VAS scores at 12,24 h in three groups had no statistical significance. The Ramsay sedative scores of the dezocine group were much higher than those of the fentany group and the tramadol group at 0.5,1 h after operation ( P 〈 0.05 ), The Ramsay sedative scores at 4,12,24 h in three groups had no sta- tistical significance (P 〈 0.05). There were no nausea and vomiting in dezocine group, 4 nausea and 0 vomiting in fentany group, and 14 nausea and 7 vomiting in tramadol group. CONCLLI- SION. Injecting the dezocine 0.1 mg/kg in vein is effective and safe when using in laparoscopic cholecgstectomy.
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第3期318-321,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 温州市科技局基金资助项目(Y20100217)
关键词 腹腔镜胆囊切除术 地佐辛 芬太尼 Laparoscopic cholecystectomy Dezocine Fentanyl Tramadol Side effect
  • 相关文献

参考文献12

二级参考文献46

共引文献872

同被引文献136

  • 1严相默.术后镇痛进展[J].中国疼痛医学杂志,2004,10(6):360-364. 被引量:51
  • 2Gharagozlou P, Hashemi E, Delorey TM, et al. Phar- macological-profiles of opioid ligands at kappa opoid receptons[J]. BMC Pharmacol, 2006, 6: 3.
  • 3毛银泉,高静.地佐辛在全髋置换术后镇痛效果观察[J].中外健康文摘,2012,9(28):256.
  • 4Cohen RI, Edwards WT, Kezer EA, et al. Serial in- travenous doses of dezocine, morphine and nalbuphine in the management of post-operative pain for outpa- tients[J]. Anesth Analg, 1993, 77(3): 533-9.
  • 5Reeves RR, Burke RS. Tramadol:basic pharmacology and emerging concepts [J]. Drugs Today, 2008, 44(11): 827-36.
  • 6Picker MJ .Discriminative stimulus effects of the mixed-opioid agonist/ antagonist dezocine: cross-substitution by mu and delta opioid agonists[J]. J Pharmacol Exp Ther, 1997,283(3):1009-1017.
  • 7Gharagozlou P, Demirci H, David Clark J,et al.Activity of opioid ligands in ceils expressing cloned mu opioid receptors [J].BMC Pharmacol, 2003 (30) : 31.
  • 8Gharagozlou P, Hashemi E, DeLorey TM, et al.Pharmacological profiles of opioid ligands at kappa opioid receptors [J]. BMC Pharmacol, 2006 (7):6 3.
  • 9Cook CD,Bartt AC, Roach EL, et al. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor [J]. Psychopharmacology (Berl), 2000,150 (4) : 430-42.
  • 10Smith MA, French AM. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats [J]. Psychopharmacology (Berl), 2002,162 (3) : 255-64.

引证文献19

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部